Our Medical Advisory Board (MAB) lends their diverse expertise to the Tourette Association of America to ensure that recommendations and materials reflect accurate and up to date information related to treatment for Tourette Syndrome and related co-occurring conditions. In addition, the MAB works with the TAA to lead the development of specific projects and initiatives aimed at improving diagnosis and treatment of Tourette Syndrome.
Barbara Coffey, M.D. MS
University of Miami Miller School of Medicine
Barbara J. Coffey, M.D., M.S., is an internationally recognized specialist in Tourette’s Disorder and related disorders. She is a Professor in the Professor in the Department of Psychiatry and Behavioral Sciences and Division Chief in the Child & Adolescent Psychiatry Department at the University of Miami Miller School of Medicine in Miami, FL.
Dr. Coffey received her B.A. in Biology-Psychology from University of Rochester, her M.D. from Tufts University School of Medicine, and M.S. in Epidemiology from Harvard University. She completed her residency in psychiatry at Boston University Hospital and her child and adolescent psychiatry fellowship at Tufts University School of Medicine.
Former Director of Pediatric Psychopharmacology at McLean Hospital and Tourette’s Clinics at McLean and Massachusetts General Hospitals from 1992-2001, Dr. Coffey remained on the faculty of the Harvard Medical School until 2007. She was Director of the Tics and Tourette’s Clinical and Research Program at NYU School of Medicine and Associate Professor in the Department of Child and Adolescent Psychiatry from 2001-2012 where she retains an Adjunct faculty position.
Dr. Coffey is the author of more than one hundred manuscripts in peer-reviewed journals, chapters and abstracts. Past and new member of the Medical Advisory Board of the TAA, Dr. Coffey is a highly sought after speaker at worldwide conferences. The recipient of numerous research grants from NIH, foundations and industry, her research has focused on phenomenology, psychiatric comorbidity, neurobiology and novel treatment of Tourette’s Disorder. Dr. Coffey has been a regular recipient of Castle Connolly’s America’s Top Doctors, and past Boston and recent New York Magazine’s “Best Doctors” honors.
Keith Coffman, M.D.
Children’s Mercy Hospital
Kansas City, MO
Keith Coffman, M.D., is an Associate Professor of Pediatrics at the University of Missouri-Kansas City School of Medicine. His clinical specialties include tics and Tourette Syndrome; movement disorders; developmental delay; neurodegenerative disorders and neurogenetic disorders. Dr. Coffman attended medical school at Pennsylvania State University College of Medicine and completed his Pediatrics and Neurodevelopmental Disabilities residencies at Children’s Hospital of Pittsburgh of UPMC. This was followed by a research fellowship in Systems Neuroscience at the University of Pittsburgh. His research focus is on the neuroanatomy of the cerebellar vermis and its role in motor control and higher cognitive function.
Shannon Bennett, Ph.D.
Weill Cornell Medical College
New York, NY
Shannon Bennett, Ph.D. is a licensed clinical psychologist with expertise in cognitive behavioral interventions for child, adolescents, and adults suffering from OCD, anxiety disorders, tic disorders, or other related conditions. Dr. Bennett is Co-Director of the Weill Cornell Pediatric OCD, Anxiety, and Tic Disorders Program (POCAT), where she provides diagnostic assessments, cognitive behavioral therapy, and consultations.
Dr. Bennett’s past clinical and academic positions include: Assistant Attending Psychologist at New York-Presbyterian Hospital, Adjunct Assistant Professor of Medical Psychology in Psychiatry at Columbia University College of Physicians and Surgeons, and Assistant Professor of Psychology in Clinical Psychiatry at Weill Cornell Medical College, Cornell University.
Dr. Bennett received her B.A., from the University of Notre Dame and her Ph.D. from Boston University.
Michael Himle, Ph.D.
The University of Utah
Salt Lake City, UT
Michael B. Himle, Ph.D. earned his Ph.D. from the University of Wisconsin-Milwaukee in 2007. He is currently an Associate Professor in the Department of Psychology at the University of Utah. He is an expert in behavioral approaches for understanding and treating behavioral disorders of childhood, with emphasis on tic disorders and associated conditions. He is active in researching environmental factors and behavioral processes involved in the onset and course of these conditions and translating this information into more effective non-pharmacological treatments. He is also interested in dissemination strategies for behavior therapy. He has published more than 40 peer-reviewed publications and book chapters and has given more than 80 conference presentations and invited talks on Tourette Syndrome and related conditions. His research has received funding from the Tourette Syndrome Association and the National Institutes of Health.
Joohi Jimenez-Shahed, M.D.
Mount Sinai Hospital
New York, NY
Joohi Jimenez-Shahed, MD is an Associate Professor of Neurology at Mount Sinai Hospital. She completed a fellowship in Movement Disorders at the Parkinson’s Disease Center and Movement Disorders Clinic (PDCMDC) at BCM. She is the Director of the Deep Brain Stimulation (DBS) Program with particular clinical and research interests in this area, but also specializes in the care of adult and pediatric patients with other movement disorders, including Tourette syndrome. Dr. Jimenez-Shahed is a member of the Parkinson Study Group, serving as co-chair of the Functional Neurosurgical Working Group. She is also an investigator with the Huntington Study Group, Clinical Research Consortium for Spinocerebellar Ataxias, Dystonia Coalition and TSA International Database of DBS Studies in Tourette Syndrome. Her research focuses on investigating the neurophysiologic correlates of movement disorders symptoms in patients undergoing DBS surgery.
Joohi Jimenez-Shahed, MD
Assistant Professor of Neurology
Associate Director, Neurology Residency Program
Director, Deep Brain Stimulator Program
Baylor College of Medicine
Parkinson’s Disease Center and Movement Disorders Clinic
7200 Cambridge, 9th Floor
MS: BCM 609
Houston, TX 77030
Monica Jones, M.D.
Dr. Monica Jones obtained her M.A. in Biology from the City University of New York, Queens College and completed her M.D. degree and pediatric residency at the State University of New York Upstate Medical University in Syracuse, NY. Dr. Jones is a Board Certified Pediatrician who has practiced in Syracuse, NY for the past 14 years. She is also a Clinical Assistant Professor at the State University of New York Upstate Medical University and a Clinical Professor at Lemoyne College Physician’s Assistant Program. Dr. Jones is an active member of the Tourette Association and is a parent of a child with TS. Dr.
Rebecca Lehman, M.D.,
Palmetto Health – USC Medical Group
Rebecca K. Lehman, MD is Associate Professor of Neurosciences (Pediatric Neurology) and Director of the Pediatric Neurology Residency Program at the Palmetto Health – USC Medical Group in Columbia, SC. She obtained her medical degree from the University of Rochester School of Medicine and Dentistry and remained at the University of Rochester for her Pediatrics preliminary years, Child Neurology residency, and Movement Disorders fellowship. Clinically, she treats pediatric patients with a wide variety of movement disorders, including Tourette syndrome, dystonia, chorea, tremor, ataxia, Parkinson’s disease, and Huntington’s disease. She was awarded the Arnold P. Gold Foundation Humanism and Excellence in Teaching Award in 2008 and was nominated for the American Medical Student Association’s and College of Medicine’s Golden Apple Award for excellence in medical education in 2011.
Irene Malaty, M.D.
University of Florida
Irene A. Malaty, M.D., is a fellowship-trained movement disorder neurologist sub-specializing in Tourette syndrome and Parkinson’s disease. She directs the multidisciplinary tic and Tourette syndrome clinic at the University of Florida in Gainesville, FL. Additionally, she is the director of the National Parkinson Foundation Center of Excellence at UF. Dr. Malaty has specific interests in compulsivity as it applies to Tourette syndrome, and in the non-motor aspects of movement disorders. She has co-authored many peer reviewed articles and has lectured domestically and internationally on Parkinson’s disease, Tourette syndrome, botulinum toxin administration, dystonia, and other movement disorders. She additionally serves on the executive board of the Florida Society of Neurology, and is the movement disorder representative on the American Academy of Neurology, Neuroendocrinology Section. In 2012, Dr. Malaty received the “Clinical Teacher of the Year” award from the UF neurology residency and a UF College of Medicine Exemplary Teachers Award.
Kirsten Mueller-Vahl, M.D.
Hannover Medical School
1983 – 1990
Medical studies at the Hannover Medical School
Dissertation entitled “The angiotensin-converting enzyme in cholestasis” (magna cum laude), Department of Gastroenterology and Hepatology of the MHH (Prof. Dr. E. Schmidt)
Internship at the Department of Neurology at MHH (Commissioner: Prof. Dr. J. Haas)
Assistant Doctor and Research Assistant at the Department of Neurology of the MHH (Director: Prof. Dr. R. Dengler)
Assistant Doctor at the Neurological Clinic of the Agnes-Karll-Hospital Laatzen (Head: Dr. R. Lorenz)
Assistant Doctor and Research Assistant at the Department of Neurology of the MHH (Director: Prof. Dr. R. Dengler)
Head of the Tourette office hours of the MHH
Funded under the Dorothea Erxleben program of the Lower Saxony Ministry of Science and Culture
Assistant Doctor and Research Assistant in the Department of Clinical Psychiatry and Psychotherapy of the MHH (Director: Prof. Dr. Dr. HM Emrich)
Recognition as a specialist in neurology
Venia legendi for “Experimental Psychiatry”; Title of the habilitation thesis “The treatment of Tourette’s syndrome with delta-9-tetrahydrocannabinol (THC)”
Participation in the first mentoring program for female scientists at the MHH, funded by the Lower Saxony Ministry of Science and Culture
Recognition as a specialist in psychiatry
Extension of Venia legendi to the field of “Psychiatry”
Senior Physician in the Department of Clinical Psychiatry and Psychotherapy of the MHH (Director: Prof. Dr. Dr. HM Emrich)
Senior physician at the Department of Psychiatry, Social Psychiatry and Psychotherapy (Director: Prof. Dr. S. Bleich)
Erika Nurmi, MD, PhD
University of California, Los Angeles
Los Angeles, CA
Erika Nurmi, MD, PhD is an Assistant Professor-in-Residence of Psychiatry and Biobehavioral Sciences in the UCLA Division of Child and Adolescent Psychiatry. She is the Medical Director of the Pediatric OCD Intensive Outpatient Program, Clinical and Research Faculty in the Child OCD, Anxiety, and Tic Disorders Program, and Teaching Clinic Supervisor and Research Faculty of the UCLA Tourette Association of America Center of Excellence. Dr. Nurmi directs a molecular and computational genetics laboratory, investigating genetic contributions to mental illness vulnerability, psychiatric endophenotypes, and response to treatment. She has co-authored many scientific publications and speaks internationally about clinical and research topics. She enjoys sharing her passion for science and medicine by teaching trainees at all levels and developing innovative educational programs. Dr. Nurmi’s aim is to integrate her roles as researcher, teacher and clinician, with the overarching goal of developing biologically based, individualized treatments for mental illness.
Michael Okun, M.D.
University of Florida
Michael S. Okun, M.D. is the Adelaide Lackner Professor of Neurology and Administrative Director for the University of Florida Center for Movement Disorders & Neurorestoration. The center is unique in that it is comprised of over 40 interdisciplinary faculty members from diverse areas of campus, all of whom are dedicated to care, outreach, education and research. Dr. Okun is the National Medical Director for the National Parkinson Foundation, the Medical Advisor to Tyler’s Hope for a Dystonia Cure, and the Co-Medical Director of the Tourette Syndrome Association. Dr. Okun has been supported by grants from the National Parkinson Foundation, the National Institutes of Health, the Parkinson Alliance, and the MJ Fox Foundation. He has over 200 peer reviewed publications, and currently his laboratory has two NIH funded projects examining Tourette Syndrome physiology and deep brain stimulation. He is currently leading the Tourette Association’s DBS Registry project.
Anthony Rostain, M.D., M.A.
University of Pennsylvania
Anthony L. Rostain, MD is a Professor of Psychiatry and Pediatrics at the University of Pennsylvania. He is currently the Director of Education for the Department of Psychiatry at the University of Pennsylvania and oversees both medical student and resident education in psychiatry. Dr. Rostain received a B.A. from Yale University in 1972, graduating Cum Laude in Philosophy and Psychology. He then went on to receive a Masters in Science Education from Southern Connecticut State College in 1974. He received his MD in 1980 from New York University School of Medicine and a Masters in Sociology in 1985 from the University of Pennsylvania. He was a Robert Wood Johnson Foundation Clinical Scholar from 1983-85 at the University of Pennsylvania after which he completed residency in adult Psychiatry at the Hospital of the University of Pennsylvania and in child and adolescent psychiatry at the Philadelphia Child Guidance Clinic. He was in charge of psychiatric services at The Children’s Hospital of Philadelphia from 1988-91 and was a founder of the region’s first program for children with Attention Deficit Hyperactivity Disorder in 1988.
Dr. Rostain’s clinical focus is “lifespan developmental neuropsychiatry” which includes patients of all ages with Attention-Deficit / Hyperactivity Disorder, Asperger’s Syndrome and High Functioning Autism, Tourette Syndrome, Learning Disabilities (verbal and nonverbal) and related social learning disorders. He treats patients at The Children’s Hospital of Philadelphia and the University Of Pennsylvania Department of Psychiatry. Dr. Rostain is the Director of the Adult Development Disorders Unit at the University of Pennsylvania which includes the Adult ADHD Treatment and Research Program and the Adult Social Learning Disorders Program. He is also Co-Director of The Children’s Hospital of Philadelphia’s Pediatric Neuropsychiatry Program.
Dr. Rostain’s research interests have focused on improving clinical outcomes for patients with neuropsychiatric disorders of all ages, and in creating effective service systems for these patients and their families. He recently completed a study of combined medication and cognitive-behavioral therapy (CBT) for adults with ADHD. He is currently involved in studies of differential therapeutic efficacy of medication and CBT, of neuropsychological functioning in ADHD patients (using behavioral measures and neuroimaging techniques), of developmental processes in young adults with ADHD, of predictors of treatment response, and of co-morbid conditions such as anxiety and substance abuse. He is also conducting research on clinical assessment and pharmacologic treatment of patients with Asperger’s Syndrome, High Functioning Autism and other Social Learning Disorders.
Jan Rowe, Dr. OT, OTR/L, FAOTA,
Children’s of Alabama
Dr. Jan Rowe, former faculty member at the University of Alabama at Birmingham, Department of Occupational Therapy started the Pediatric Tourette syndrome/ tic disorder at UAB in January of 2010. Since her retirement from UAB (Dec. 2012) the clinic has moved to the Children’s Hospital System of Alabama. Dr. Rowe is the first occupational therapist to coordinate a CBIT clinic and has begun training other occupational therapists to work with children who have Tourette Syndrome or Tic disorders. She and Dr. Dure (Children’s Hospital) are working on a Tourette Association grant with Cornell to manualize CBIT for occupational therapists. Through her clinic occupational therapists have been found to be effective at delivering CBIT and offer another route to therapy for families (Rowe, Yuen & Dure, 2013). Jan received her doctorate from NOVA Southeastern University in Ft. Lauderdale, Fl. In 2004, her Master’s in Public Health from UAB (1990) and did her undergraduate work in Occupational Therapy at the University of Central Arkansas (1982).
Dr. Sabine Wilhelm
Harvard Medical School
Dr. Sabine Wilhelm is a Professor of Psychology at Harvard Medical School. She is the Chief of Psychology and the Director of the Obsessive-Compulsive and Related Disorders Program at Massachusetts General Hospital.
Dr. Wilhelm is recognized as a leading researcher in tic disorders, obsessive-compulsive disorder (OCD) and body dysmorphic disorder and has published over 200 articles and reviews on cognitive functioning, prevalence and treatment outcomes of these disorders. She has also given more than 190 invited lectures and presentations on these subjects. Dr. Wilhelm has published seven books on OCD, BDD and tic disorders.
She has been a mentor to more than 40 junior investigators in the field. Dr. Wilhelm is the Vice Chair of the Scientific Advisory Board of the International OCD Foundation, and she serves on the Scientific Council for the Anxiety and Depression Association of America as well as on the Tourette Association of America Behavioral Science Consortium. Dr. Wilhelm served as the Representative-at-Large for the Association for Behavioral and Cognitive Therapies (ABCT) from 2012-2015. She is President-Elect for ABCT from 2017-2018.
Dr. Wilhelm was an Associate Editor for the journals Depression and Anxiety and Behavior Therapy. She currently serves on eight editorial boards. In 2002, she was awarded the Claflin Distinguished Scholar in Medicine Award. She was named a Beck Institute Scholar in 2003, and was also the Scientific Program Chair of the World Congress of Behavioral and Cognitive Therapies held in Boston in June 2010.
Dr. Wilhelm has been the principal investigator or site principal investigator of seven NIMH-funded research grants. She is also the principal investigator of several privately-funded clinical research studies investigating medication, cognitive-behavioral therapy and other treatments for OCD, BDD and tic disorders in children and adults.
Douglas Woods, Ph.D.
Douglas Woods, Ph.D. is currently Dean of the Graduate School and Professor of Psychology at Marquette University. Dr. Woods has been working in the Tourette field for over 20 years. He has written over 250 articles and 9 books, including the CBIT treatment manual; and has received over $4 million in research funding for Tourette and related conditions. Through the TAA’s Behavior Therapy Institute program, Dr. Woods is a co-developer of the online self-help CBIT program www.tichelper.com, and he has trained hundreds of practitioners to do CBIT in North America, Europe and Australia. Dr. Woods is a Fellow of the American Psychological Association and the Association for Behavioral and Cognitive Therapies. He is a former co-chair of the Tourette Association of America’s Medical Advisory Board (MAB) and remains an active member of the MAB.